Showing results (621-630 of 816) with videos related to
Sort By:
Pageof 82
The Journal of Biological Chemistry|March 8, 2019
Design and characterization of mutant and wildtype huntingtin proteins produced from a toolkit of scalable eukaryotic expression systemsRachel J Harding, Peter Loppnau, Suzanne Ackloo, et al.European Journal of Biochemistry|February 13, 2001
Chaperone function of mutant versions of alpha A- and alpha B-crystallin prepared to pinpoint chaperone binding sitesB K Derham, M A van Boekel, P J Muchowski, et al.Biorxiv : the Preprint Server for Biology|October 10, 2024
Challenges and advances for huntingtin detection in cerebrospinal fluid: in support of relative quantificationRachel J Harding, Yuanyun Xie, Nicholas S Caron, et al.Scientific Reports|June 12, 2023
Accurate, non-destructive, and high-throughput age estimation for Golden perch (Macquaria ambigua spp.) using DNA methylationBenjamin Mayne, Tom Espinoza, David A Crook, et al.Journal of Vascular and Interventional Radiology : JVIR|March 15, 2025
Outcomes of Transarterial Hepatic Embolization versus Yttrium-90 Radioembolization for Treatment of Patients with Hepatocellular Carcinoma >7 cmSam Y Son, Sara Velayati, Ken Zhao, et al.Investigational New Drugs|August 4, 2018
Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitorJames J Harding, Todd M Bauer, Daniel S W Tan, et al.Antimicrobial Agents and Chemotherapy|February 6, 2023
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic ModelingM T Chirehwa, J E Resendiz-Galvan, R Court, et al.Cancer Research Communications|April 11, 2024
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid TumorsBenjamin Garmezy, Mitesh J Borad, Rastilav Bahleda, et al.Hepatology (Baltimore, Md.)|July 12, 2016
Liver kinase B1 regulates hepatocellular tight junction distribution and function in vivoNatalie Porat-Shliom, Amber J Tietgens, Christina M Van Itallie, et al.Mayo Clinic Proceedings|May 7, 2014
Serum polyclonal immunoglobulin free light chain levels predict mortality in people with chronic kidney diseaseColin A Hutchison, Anne Burmeister, Stephen J Harding, et al.Pageof 82